title: Reduction in human melanoma cell adhesion receptor activity by lysophosphatidylcholine (LPC) treatment - functional characterization and signal pathway analyses.
authors.affiliation: Department of Genomics, LIFE & BRAIN Center GmbH, Bonn, Germany. michael.alexander@uni-bonn.de
authors.forename: M
authors.initials: M
authors.lastname: Alexander
authors.forename: M
authors.initials: M
authors.lastname: Schlesinger
authors.forename: P
authors.initials: P
authors.lastname: Jantscheff
authors.forename: U
authors.initials: U
authors.lastname: Massing
authors.forename: G
authors.initials: G
authors.lastname: Bendas
mesh_terms: D000368:Aged; D002448:Cell Adhesion / Q000187:drug effects; D045744:Cell Line, Tumor; D020869:Gene Expression Profiling; D006801:Humans; D016023:Integrins / Q000502:physiology; D008244:Lysophosphatidylcholines / Q000494:pharmacology*; D008545:Melanoma / Q000473:pathology / Q000556:secondary*; D015398:Signal Transduction / Q000187:drug effects*
chemical_list: D016023:Integrins; D008244:Lysophosphatidylcholines